How Important Are Hematological Parameters in the Prognosis of Severe Covid-19 Patients?

CompletedOBSERVATIONAL

Enrollment

125

Participants

Timeline

Start Date

March 1, 2020

Primary Completion Date

December 31, 2021

Study Completion Date

September 30, 2022

Conditions

COVID-19

Interventions

DIAGNOSTIC_TEST

Hemogram

Sysmex XN-1000 hematological analyzer

Trial Locations (1)

Hisar Hospital Intercontinental, Istanbul

All Listed Sponsors

lead

Hisar Intercontinental Hospital

OTHER

NCT05650944 - How Important Are Hematological Parameters in the Prognosis of Severe Covid-19 Patients? | Biotech Hunter | Biotech Hunter